Camlin Fine Sciences Overview
- Founded
- 1931
- Status
- Public
- Employees
- 382
- Stock Symbol
- 532834
- Investments
- 3
- Share Price
- $1.54
- (As of Thursday Closing)
Camlin Fine Sciences General Information
Description
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The company's product portfolio consists of Shelf life extension solutions, Aroma ingredients, and Performance chemicals. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate, agrochemicals and fragrance industry. Their products are marketed across Europe, the Asia Pacific and India.
Contact Information
Website
Formerly Known As
Camlin Fine Chemicals
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Specialty Chemicals
Other Industries
Other Chemicals and Gases
Commodity Chemicals
Stock Exchange
BOM
Primary Office
- F/11-12, WICEL, Opposite SEEPZ, Central Road
- Andheri (East)
- Mumbai, Maharashtra 400093
- India
+91 022 0000 0000
Camlin Fine Sciences Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.54 | $1.59 | $0.43 - $1.81 | $187M | 127M | 63K | $0.03 |
Camlin Fine Sciences Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 258,426 | 128,541 | 128,465 | 249,773 |
| Revenue | 152,032 | 146,404 | 126,201 | 110,854 |
| EBITDA | 18,463 | 16,390 | 9,956 | 3,529 |
| Net Income | 3,950 | 4,267 | 82 | (4,598) |
| Total Assets | 176,219 | 163,625 | 156,487 | 156,134 |
| Total Debt | 67,590 | 71,402 | 66,363 | 57,263 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Camlin Fine Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Camlin Fine Sciences‘s full profile, request access.
Request a free trialCamlin Fine Sciences Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Santosh Parab | Chief Financial Officer | ||
| Ashish Dandekar | Managing Director |
Camlin Fine Sciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCamlin Fine Sciences Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 00000000 00 | 12-Jul-2017 | 000000000000000000 | 00.000 | Food Products | |
| 000000 00í0000 | 05-May-2016 | 000000000000000000 | 00.00 | Industrial Chemicals | |
| Dulcette Technologies | 07-Jul-2008 | Joint Venture | Specialty Retail |
Camlin Fine Sciences Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 00í0000 | Industrial Chemicals | Mexico City, Mexico | 0000 |
Camlin Fine Sciences Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 000000000 | 07-Jul-2008 | 00000 0000000 | Completed |
|